Q3 Medical Devices
Ireland-based medical device holding company developing biodegradable and minimally invasive catheter-based implants for biliary, pancreatic, peripheral vascular, and coronary applications, with own-branded and OEM distribution through subsidiaries in Germany, China, and the US across 30+ countries.
- Company typePrivate
- Founded2013
- HeadquartersDublin, Ireland
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Q3 Medical Devices does
Q3 Medical Group is an Ireland-based privately held medical device holding company that develops, manufactures, and commercializes biodegradable and minimally invasive catheter-based implant technologies for interventional cardiology, peripheral vascular, and non-vascular (primarily biliary and pancreatic) applications. The group operates four wholly owned subsidiaries — QualiMed Innovative Medizinprodukte GmbH and AMG International GmbH (both founded 1997 in Germany for manufacturing and channel respectively), Q3 Medical Devices (Shanghai) Co. Ltd. (Q-San, China manufacturing), and QualiMed USA, LLC (Charlotte, North Carolina, US market entry) — and was assembled by a consortium of medical device entrepreneurs, manufacturers, distributors, clinicians, and investors.
The company's product architecture spans three technology platforms. The biodegradable platform centers on a magnesium-and-polymer hybrid stent chemistry that supports the ARCHIMEDES biliary and pancreatic stent (the world's first CE-approved bioresorbable replacement for plastic biliary stents) and the UNITY-B family of percutaneous and endoscopic balloon expandable biodegradable biliary stents, both designed to eliminate removal procedures and mitigate the in-growth, over-growth, and perforation complications associated with traditional metal stents. The Mini Invasive Technologies platform delivers up to 6F-compatible peripheral vascular devices (PSpp self-expanding stent, QBX 35 balloon expandable stent, PVQ 35 and PVQ 35 HP PTA balloon catheters, and VX 6F aspiration catheter). The Micro Invasive Technologies platform covers 4F/5F devices used in procedures requiring minimal puncture site diameter. The portfolio is backed by more than 70 patents and utility models worldwide.
Revenue is generated through two parallel channels: branded product sales via AMG International's network of approximately 20 distributors reaching more than 30 countries across Europe, Asia, South America, and the Middle East, and OEM manufacturing for major global medical device companies (a legacy of QualiMed's founding role). The group holds CE approvals for mechanical implants, catheter-based technologies, drug-device combination products, and biodegradable technologies, and is pursuing US FDA IDE clearance for ARCHIMEDES via its Charlotte subsidiary. Strategic investors include China Pioneer Pharma Holdings (HKEX: 1345) and Boill Holding Group. Within the addressable interventional cardiology, peripheral vascular, and non-vascular markets (described as $20B+), the company is targeting replacement of 1.5 million annual plastic biliary stents globally and 500,000 in the US alone.
Q3 Medical Devices firmographics
Firmographics- Name
- Q3 Medical Devices
- Legal name
- Q3 Medical Group
- Website
- https://q3medical.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Ireland-based medical device holding company developing biodegradable and minimally invasive catheter-based implants for biliary, pancreatic, peripheral vascular, and coronary applications, with own-branded and OEM distribution through subsidiaries in Germany, China, and the US across 30+ countries.
- Ownership category
- akta.pro rank
Q3 Medical Devices industry classification
Industry- Product category
- Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
- akta.pro secondary industry
- Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)
Keywords
Where Q3 Medical Devices is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Offices4 records
Markets served
Q3 Medical Devices business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations
Revenue model
- Medical Device Sales: Q3 Medical Group generates revenue through the sale of its own branded medical device products (biodegradable stents, balloon catheters, aspiration catheters, and stent systems) across interventional cardiology, peripheral vascular, and non-vascular specialties. The group also operates as an OEM manufacturer designing and producing implantable stent devices for major global medical device companies.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels1 record
Q3 Medical Devices product offering
Product offeringCore offering
Q3 Medical Devices is a medical device manufacturer focused on biodegradable stents and minimally invasive medical technologies. The company develops and produces stent products for endoscopic and percutaneous clinical applications, sold under multiple branded product lines.
Product overview
Q3 Medical Group is a medical device company organized as a platform-plus-modules architecture. The company operates through three main product platforms: Biodegradable Technologies (including ARCHIMEDES and UNITY-B biodegradable stents), Mini Invasive Technologies (up to 6F devices including stents, balloons, and aspiration catheters), and Micro Invasive Technologies (4F/5F devices). The biodegradable product line (ARCHIMEDES, UNITY-B Endoscopic, UNITY-B Percutaneous) focuses on biliary and pancreatic applications with the key benefit of eliminating removal procedures. The peripheral vascular product line (PSpp, QBX 35, PVQ 35, PVQ 35 HP, VX 6F) addresses broader vascular interventions. The company also maintains manufacturing operations through QualiMed (Germany), Q-San China, and Q3 Medical USA, supporting both proprietary branded products and OEM manufacturing capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- ARCHIMEDES: Biodegradable Biliary and Pancreatic Stent - World's first CE approved Bioresorbable replacement for plastic biliary stents.
- UNITY-B
- MINI Invasive Technologies
- MICRO Invasive Technologies
Products and services
- ARCHIMEDES Biodegradable stent product in Q3 Medical Devices' portfolio.
- UNITY-B (Endoscopic & Percutaneous) Biodegradable stent offering available in endoscopic and percutaneous delivery variants for minimally invasive implantation.
- PSpp Stent product within Q3 Medical Devices' portfolio.
- QBX 35 Stent product within Q3 Medical Devices' portfolio.
- PVQ 35 Stent product within Q3 Medical Devices' portfolio.
- PVQ 35 HP Stent product within Q3 Medical Devices' portfolio.
- VX Product within Q3 Medical Devices' portfolio.
Quantifiable outcome
- Eliminates removal procedures required for plastic stents at maximum 90 days post-implant, removing $5,000-$10,000 US facility fees per removal
- +2 more outcomes
Companies that use Q3 Medical Devices
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles1 record
Q3 Medical Devices technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Q3 Medical Devices partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Merit MedicalminorEric K Mangiardi, President & CEO of Q3 Medical Group, previously founded Alveolus which was acquired by Merit Medical and now forms the foundation of their Merit Endotek Division. This represents a past acquisition of a company led by Q3 leadership, not an active partnership.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Q3 Medical Devices competitors and assessment
Company assessmentBroad incumbents
- Terumo: Global interventional systems and stent manufacturer with overlapping peripheral vascular and access product lines serving similar accounts.
- Becton, Dickinson and Company (BD): Broad medical devices player with meaningful peripheral vascular and surgical franchises that overlap with Q3's minimally invasive portfolio.
- Boston Scientific: Broad interventional cardiology, peripheral vascular, and GI portfolio; overlaps with Q3 across stents, PTA balloons, and biliary products as an established incumbent.
- Medtronic: Major player in interventional cardiology and peripheral vascular devices, competing head-on with Q3's coronary and peripheral stent portfolio.
- Olympus (Medical): Dominant position in GI endoscopy where ARCHIMEDES and UNITY-B are deployed; competes for ERCP and biliary drainage procedure share.
- Abbott (Cardiovascular): Historical reference point in bioresorbable scaffolds (Absorb); competes broadly in coronary stents and vascular intervention against Q3.
Direct peers
- Penumbra: Specialises in aspiration and thrombectomy catheters (e.g., Indigo), making it a direct peer to Q3's VX 6F aspiration catheter in coronary and peripheral thrombus removal.
- AngioDynamics: Operates in peripheral vascular disease and oncology intervention with comparable catheter and stent products targeting similar clinical accounts.
- Cook Medical: Established leader in GI and biliary stenting, directly competing with ARCHIMEDES and UNITY-B in endoscopic and percutaneous biliary applications.
- Merit Medical Systems: Acquired Alveolus (founded by Q3's current CEO), which now forms the Merit Endotek Division. Directly comparable in peripheral vascular stents, aspiration catheters, and GI non-vascular devices.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Q3 Medical Devices social profiles
Digital presenceQ3 Medical Devices financial estimates
Financial estimateRevenue estimate
Valuation estimate
Q3 Medical Devices leadership team
Management profileNumber of profiles
Q3 Medical Devices subsidiaries and ownership
Company hierarchySubsidiaries4 records
Q3 Medical Devices funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Q3 Medical Devices M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Q3 Medical Devices
What does Q3 Medical Devices do?
Q3 Medical Devices is a medical device manufacturer focused on biodegradable stents and minimally invasive medical technologies. The company develops and produces stent products for endoscopic and percutaneous clinical applications, sold under multiple branded product lines.
Is Q3 Medical Devices a public or private company?
Q3 Medical Devices is a private company. It is classified as unknown and is currently operating.
When was Q3 Medical Devices founded?
Q3 Medical Devices was founded in 2013. It employs 101 to 250 people.
Where is Q3 Medical Devices based?
Q3 Medical Devices is headquartered in Dublin, Ireland, in the Europe region.
How does Q3 Medical Devices make money?
One revenue line is on record: medical Device Sales.
Who are Q3 Medical Devices's main competitors?
Broad incumbents on record are Terumo, Becton, Dickinson and Company (BD), Boston Scientific, Medtronic, Olympus (Medical) and Abbott (Cardiovascular). Direct peers are Penumbra, AngioDynamics, Cook Medical and Merit Medical Systems.
Does Q3 Medical Devices have an API?
No public API is recorded for Q3 Medical Devices.
What industry is Q3 Medical Devices in?
Q3 Medical Devices's product category is Medical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 339112 and its SIC code is 3841.